Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News AtriCure Inc ATRC

Healthcare Medical Devices
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze... see more

Recent & Breaking News (NDAQ:ATRC)

AtriCure to Announce First Quarter 2014 Financial Results

Business Wire April 4, 2014

AtriCure to Present at the Cowen and Company 34th Annual Health Care Conference

Business Wire February 28, 2014

AtriCure Reports Fourth Quarter and Full Year 2013 Financial Results

Business Wire February 27, 2014

AtriCure Prices Public Offering of Common Stock

Business Wire February 13, 2014

AtriCure Announces Commencement of Public Offering of Common Stock

Business Wire February 12, 2014

AtriCure to Announce Fourth Quarter and Full Year 2013 Financial Results

Business Wire February 4, 2014

AtriCure to Present at the Leerink Swann 2014 Global Healthcare Conference

Business Wire January 20, 2014

AtriCure Announces Preliminary Results for Fourth Quarter and Full Year 2013 and Issues 2014 Guidance

Business Wire January 9, 2014

AtriCure Completes Acquisition of Estech

Business Wire January 2, 2014

AtriCure Announces Definitive Agreement to Acquire Estech

Business Wire December 19, 2013

AtriCure Receives FDA Approval for Investigational Study to Evaluate Stroke Prevention in Atrial Fibrillation

Business Wire November 19, 2013

AtriCure Announces Upcoming Investor Conference Schedule

Business Wire October 31, 2013

AtriCure to Announce Third Quarter 2013 Financial Results

Business Wire October 7, 2013

In the Fight Against Atrial Fibrillation, AtriCure Launches Maze IV Training Program in Europe

Business Wire October 1, 2013

Health Risks of Atrial Fibrillation Raised During Awareness Month

Business Wire September 19, 2013

AtriCure Announces Commitment to Improve Lives of 250,000 Atrial Fibrillation Patients

Business Wire September 18, 2013

BioSig Technologies, Inc. Appoints David J. Drachman as Chief Executive Officer & Chairman

Globe Newswire September 18, 2013

AtriCure Appoints Scott Drake to Its Board of Directors

Business Wire September 3, 2013

AtriCure and Century Medical Expand, Secure Distribution Agreement

Business Wire August 22, 2013

AtriCure to Announce Second Quarter 2013 Financial Results

Business Wire July 10, 2013